The Silicon Review
Company | Management | Description |
Apitope www.apitope.com |
Hayley French, CEO | Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases. |
Atossa Therapeutics Inc atossatherapeutics.com |
Steven C. Quay, Chairman & CEO |
Atossa Therapeutics is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19. |
Notable Labs www.notablelabs.com |
Laurie Heilmann, CEO | Notable Labs is a translationally focused drug development company that uses a clinically validated, automated compound sensitivity platform to identify and advance novel therapeutic candidates to dramatically reduce the cost and time of the traditional drug development process. |
Aviceda Therapeutics www.avicedarx.com |
Mohamed A. Genead, MD (Founder, Chairman of Board & CEO) | Aviceda Therapeutics is a stealth stage biotech company focused on the next generation of glyco-immune therapeutics utilizing the Glyco-Code technology to address the innate immune system and chronic non-resolving inflammation. |
Lumen www.lumen.bio |
Brian Finrow, Co-founder & CEO | Lumen’s patented biologic drug platform shortens the development process, reduces costs and risks, and accelerates time-to-market, making us the first company to make orally delivered antibody drugs commercially viable. |